21 mayo 2015
A new chemical technology uses cancer cells’ own protein-degrading machinery to destroy, rather than merely inhibit, cancer proteins. Researchers developed the strategy as a way to develop inhibitors of «undruggable» proteins and overcome drug resistance, a common shortcoming of targeted therapies. Resistance arises when tumors that originally responded to a particular therapy manage to circumvent the drug’s effects and resume their growth.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ywEaTcfJxYo/150521144032.htm
